April 29 (Reuters) – British consumer healthcare group Haleon on Wednesday reported first quarter revenue growth slightly below analyst expectations, as weakness in other international markets was partially balance out by growth in North America.
Haleon, which has been struggling with weakening demand and stiff competition in the U.S., its largest market, has been revamping leadership and distribution channels in the region and now expects North American growth to accelerate through the year.
The Sensodyne toothpaste maker reported organic revenue growth of 2.2% for the three months through March, compared to analysts’ expectations of 2.3%, according to the company-compiled consensus.
It reiterated expectations for 3-5% organic revenue growth and high-single digit adjusted operating profit growth in 2026.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Ronojoy Mazumdar)
Comments